However, a recent study13 reported that PD-1+CD8+ immune subsets are associated with improved survival in triple-negative breast cancer (TNBC), while the CD8-PD-1+ immune subset was not associated. The gene discussed is CD8A; the disease is triple-negative breast carcinoma.